Enalees and AB ANALITICA Announce New Partnership to Advance Animal Health in Italy
July 25, 2024 – Enalees, a leading biotech company in veterinary diagnostics, is excited to announce a strategic partnership with AB ANALITICA, a renowned company specializing in molecular diagnostics. This collaboration aims to enhance animal health through the development and distribution of cutting-edge diagnostic solutions.
The partnership between Enalees and AB ANALITICA represents a significant milestone in the veterinary diagnostics industry. By combining Enalees’ expertise in rapid, point-of-care diagnostic tools with AB ANALITICA’s molecular diagnostic market knowledge in Italy, the two companies are set to provide veterinarians with more accurate, efficient, and comprehensive diagnostic solutions.
Smooth navigation can make a noticeable difference for casino players who want less time searching and more time enjoying slots, tables, and live-style action. A visit to https://online-roulette-real-money-australia.com/winspirit-roulette-australia/ gives players a direct route to another online casino environment with games to explore. Familiar favourites and newer discoveries can sit comfortably together, giving each visit a different rhythm.
We are thrilled to partner with AB ANALITICA, their expertise in molecular diagnostics perfectly complements our mission to deliver rapid and reliable diagnostic tools to veterinarians. Together, we can significantly improve disease detection and management, ultimately enhancing the well-being of animals in Italy.
said Laurent Thiery, Founder and President of Enalees
We are honoured to partner with Enalees in this significant collaboration to advance animal health diagnostics in Italy. This partnership brings together our extensive expertise in molecular diagnostics with Enalees’ innovative approach to rapid, point-of-care diagnostic tools. Together, we aim to provide veterinarians with the most accurate and efficient diagnostic solutions available, ultimately enhancing the health and well-being of animals. We find the collaboration with Enalees very interesting and useful for developing technological synergies in the field of diagnostic molecular biology, aimed at both the human and veterinary sectors. The health of mankind depends very much on the health of animals. At AB ANALITICA, we are committed to pioneering advancements in healthcare, and this partnership aligns perfectly with our mission to deliver high-quality, reliable diagnostic products. We look forward to the positive impact this collaboration will have on the veterinary community and animal health.
said Dino Paladin, Founder of AB ANALITICA
About AB ANALITICA
AB ANALITICA is a company dedicated to revolutionizing healthcare through innovative diagnostic solutions. Established in 1990, it has over 30 years of experience in the field of molecular diagnostics, providing in vitro diagnostics to improve patient outcomes. With its headquarters in Padua, the company boasts extensive laboratories for production and research, ensuring high-quality standards across its products.
The company’s innovation is driven by a multidisciplinary team of experts in biotechnology, engineering, computer science, and pharmacogenetics. This diverse expertise allows AB ANALITICA to offer comprehensive solutions, including kits for DNA/RNA extraction and amplification, breath tests for disease diagnosis, and fertility and quality control products. The company also focuses on molecular biology, with syndromic panels for infectious diseases and genetic disorders.
AB ANALITICA emphasizes stringent quality control, evidenced by its certifications, including ISO and CE-IVD marks, and compliance with the EU’s IVDR regulations. It collaborates with TÜV SÜD, a respected Notified Body, to maintain the highest standards in medical diagnostic devices. Transparency and ethical standards are central to its operations, ensuring customer trust and confidence.
Furthermore, AB ANALITICA is committed to environmental stewardship, actively working to reduce energy consumption and minimize emissions. The company’s robust organizational structure supports a comprehensive approach to customer care, from sales to after-sales service and technical support. In marketing, AB ANALITICA employs a strategic approach, leveraging social media, trade fairs, webinars, and a well-maintained website to reach its audience and support its sales efforts. Overall, AB ANALITICA stands as a leader in biotech, with a clear focus on quality, innovation, and customer satisfaction.
For further information, visit https://www.abANALITICA.com/
About Enalees
Enalees develops and produces rapid isothermal PCR diagnostic tests which enable veterinary professionals to diagnose infectious diseases – both in their veterinary practices and in the field – without the need to send samples to an external laboratory. Its team, which is primarily made up of doctors, engineers and biology technicians, has a particular focus on the development of innovative tests for domesticated animals (horses, dogs and cats).
Based on an isothermal amplification technique, the company’s products can detect over 20 infectious & respiratory diseases in horses (such as Herpes virus or equine influenza) and in dogs and cats (such as coryza, entheropathies, or even hemobartonellose) making it the French market leader in veterinary LAMP PCR (Loop-mediated isothermal AMPlification Polymerase Chain Reaction). Enalees’ tests are currently available in Europe directly from Enalees’ Group (France, United Kingdom and Germany) or through its distributors network.
Founded in 2015, Enalees moved to the Genopole research center (France) in 2016, where it later set up its own lyophilization platform. This new facility enabled the company to increase its production capacity to over one million tests a year, including products for its own animal health business as well as custom tests for its partners.
Enalees now employs 44 staff. For further information, visit enalees.com